Genetic Predisposition to High-Altitude Pulmonary Edema
High Altitude Medicine & Biology · 01.03.2020 · 21 (1) · 28-36
DOI: 10.1089/ham.2019.0083 ↗Kurz gefasst
Fachartikel in der Zeitschrift High Altitude Medicine & Biology, online erschienen am 17.03.2020. Verfasst von Christina A Eichstaedt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pulmonary Hypertension, Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Altitude Sickness, Hypertension, Pulmonary, Pulmonary Edema. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Background
Exaggerated pulmonary arterial hypertension (PAH) is a hallmark of high-altitude pulmonary edema (HAPE). The objective of this study was therefore to investigate genetic predisposition to HAPE by analyzing PAH candidate genes in a HAPE-susceptible (HAPE-S) family and in unrelated HAPE-S mountaineers. Materials and Methods: Eight family members and 64 mountaineers were clinically and genetically assessed using a PAH-specific gene panel for 42 genes by next-generation sequencing.
Results
Two otherwise healthy family members, who developed re-entry HAPE at 3640 m during childhood, carried a likely pathogenic missense mutation (c.1198T>G p.Cys400Gly ) in the Janus Kinase 2 ( JAK2 ) gene. One of them progressed to a mild form of PAH at the age of 23 years. In two of the 64 HAPE-S mountaineers likely pathogenic variants have been detected, one missense mutation in the Cytochrome P1B1 gene, and a deletion in the Histidine-Rich Glycoprotein ( HRG ) gene.
Conclusions
This is the first study identifying an inherited missense mutation of a gene related to PAH in a family with re-entry HAPE showing a progression to borderline PAH in the index patient. Likely pathogenic variants in 3.1% of HAPE-S mountaineers suggest a genetic predisposition in some individuals that might be linked to PAH signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Pulmonary Hypertension, Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany.
- Laboratory of Molecular Genetic Diagnostics, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
- Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
- Medical Clinic VII, Sports Medicine, University Hospital Heidelberg, Heidelberg, Germany.
- Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
- Medbase Checkup Center, Zurich, Switzerland.
Zitieren
APA
Eichstaedt, C. A., Mairbäurl, H., Song, J., Benjamin, N., Fischer, C., Dehnert, C., Schommer, K., Berger, M. M., Bärtsch, P., Grünig, E., & Hinderhofer, K. (2020). Genetic Predisposition to High-Altitude Pulmonary Edema. High Altitude Medicine & Biology, 21(1), 28-36. https://doi.org/10.1089/ham.2019.0083
Vancouver
Eichstaedt CA, Mairbäurl H, Song J, Benjamin N, Fischer C, Dehnert C, et al. Genetic Predisposition to High-Altitude Pulmonary Edema. High Altitude Medicine & Biology. 2020;21(1):28-36. doi:10.1089/ham.2019.0083
BibTeX
@article{Eichstaedt2020,
author = {Eichstaedt, Christina A and Mairbäurl, Heimo and Song, Jie and Benjamin, Nicola and Fischer, Christine and Dehnert, Christoph and Schommer, Kai and Berger, Marc M and Bärtsch, Peter and Grünig, Ekkehard and Hinderhofer, Katrin},
title = {Genetic Predisposition to High-Altitude Pulmonary Edema},
journal = {High Altitude Medicine & Biology},
year = {2020},
volume = {21},
number = {1},
pages = {28--36},
doi = {10.1089/ham.2019.0083}
}
EUVIMED